NFlection Therapeutics

Boston, United States

NFlection Therapeutics is a biopharmaceutical company focusing on targeted treatments for rare diseases.

$20.0M raised

Jun 2022

Series B

Biotechnology Medical Pharmaceutical Therapeutics

Top Investors

F-Prime Eight Roads Ventures venBio Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NFlection Therapeutics

How much funding has NFlection Therapeutics raised?

NFlection Therapeutics has raised $20.0M in total funding. The most recent round was Series B. The last funding was announced in June 2022.

Who are NFlection Therapeutics's investors?

NFlection Therapeutics's investors include F-Prime, Eight Roads Ventures, venBio Partners.

Where is NFlection Therapeutics headquartered?

NFlection Therapeutics is headquartered in Boston, United States.

What does NFlection Therapeutics do?

NFlection Therapeutics is a biopharmaceutical company focusing on targeted treatments for rare diseases.

What stage is NFlection Therapeutics at?

NFlection Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 9, 2022.

MLA

"NFlection Therapeutics — Funding & Investors." VCBacked, June 9, 2022, https://www.vcbacked.co/company/nflection-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). NFlection Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nflection-therapeutics

Wikipedia (cite web)

{{cite web |title=NFlection Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nflection-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 9, 2022.